HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hosokawa, R. Articles by Sasayama, S. Search for Related Content PubMed PubMed Citation Articles by Hosokawa, R. Articles by Sasayama, S.

Myocardial Kinetics of Iodine-123-BMIPP in Canine Myocardium After Regional Ischemia and Reperfusion: Implications for Clinical SPECT

Third Division, Departments of Internal Medicine and Nuclear Medicine, Kyoto University Hospital, and Department of Genetic Biochemistry, Faculty of Pharmaceutical Sciences, Kyoto University; Kyoto, Japan

Correspondence: For correspondence or reprints contact: Ryuji Nohara, MD, Third Division, Department of Internal Medicine, Kyoto University Hospital, 54 Kawaracho, Shogoin, Sakyoku, Kyoto City, 606 Japan.

ABSTRACT

To evaluate the clinical utility of ¹²³I-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (¹²³I-BMIPP) for ischemic heart disease, we investigated the metabolic fate of ¹²³I-BMIPP in canine models with mild and severe ischemia and evaluated the clinical utility of this tracer. Methods: Using open-chest dogs under anesthesia, we assembled a system that would release all the blood from the great cardiac vein without recirculation, if necessary. After injection of BMIPP into the left anterior descending coronary artery, blood samplings from cardiac vein and abdominal aorta were performed for 10-min ischemia (mild ischemia, five dogs) and 30-min ischemia (severe ischemia, six dogs), after reperfusion and for normal controls (six dogs). The catabolites of BMIPP, including backdiffusion of nonmetabolized BMIPP, were evaluated using high-performance liquid chromatography. Results: Although the rapid extraction of BMIPP from the plasma into the myocardium and the subsequent retention were unchanged among three groups, the early washout (at 8 min) of radioactivity significantly increased (from 50% ± 13% to 61% ± 8%; p < 0.05) in severe ischemia. The metabolites from the myocardium consisted of backdiffusion of nonmetabolized BMIPP and alpha-oxidation, intermediate-oxidation and full-oxidation metabolites. For mild ischemia, these values were not significantly changed from the normal control, although the respective propor tions of metabolites showed some variation. Lactate production after reperfusion on mild ischemia, which indicates the severity of ischemia,was closely correlated with the level of backdiffusion of BMIPP (r = –0.92) and the full-oxidation metabolite (r = 0.78). On the other hand, for severe ischemia, the level of backdiffusion of nonmetabolized BMIPP increased (from 25.1% ± 8.0% to 34.7% ± 8.7%; p < 0.05), and the full-oxidation metabolites decreased (from 21.4% ± 10.9% to 14.8% ± 7.3%). Conclusion: The metabolism of BMIPP was closely associated with the severity of myocardial ischemia. Thus,¹²³I-BMIPP might be a promising and sensitive radiopharmaceutical for the evaluation of ischemic heart disease.

Key Words: iodine-123-BMIPP • ischemic heart disease • fatty acids

This article has been cited by other articles:

				V. Dilsizian and J. C. Fink Deleterious Effect of Altered Myocardial Fatty Acid Metabolism in Kidney Disease J. Am. Coll. Cardiol., January 15, 2008; 51(2): 146 - 148. [Full Text] [PDF]

				V. Dilsizian, T. M. Bateman, S. R. Bergmann, R. Des Prez, M. Y. Magram, A. E. Goodbody, J. W. Babich, and J. E. Udelson Metabolic Imaging With {beta}-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia Circulation, October 4, 2005; 112(14): 2169 - 2174. [Abstract] [Full Text] [PDF]

				K. Kitagawa, K. Takeda, K. Saito, S. Okamoto, K. Makino, H. Maeda, and T. Ichihara Differences in Fatty Acid Metabolic Disorder Between Ischemic Myocardium and Doxorubicin-Induced Myocardial Damage: Assessment Using BMIPP Dynamic SPECT with Analysis by the Rutland Method J. Nucl. Med., October 1, 2002; 43(10): 1286 - 1294. [Abstract] [Full Text] [PDF]

				M. Nanasato, A. Ando, S. Isobe, M. Nonokawa, H. Hirayama, N. Tsuboi, T. Ito, M. Hirai, M. Yokota, and H. Saito Evaluation of Left Ventricular Function Using Electrocardiographically Gated Myocardial SPECT with 123I-Labeled Fatty Acid Analog J. Nucl. Med., December 1, 2001; 42(12): 1747 - 1756. [Abstract] [Full Text] [PDF]

				T. Sakamoto, M. Aoki, Y. Imai, and S. Nemoto Carnitine affects fatty acid metabolism after cardioplegic arrest in neonatal rabbit hearts Ann. Thorac. Surg., February 1, 2001; 71(2): 648 - 653. [Abstract] [Full Text] [PDF]

				K. Kataoka, R. Nohara, R. Hosokawa, T. Hirai, K. Okuda, C. Li-Guang, Y. Fujibayashi, M. Fujita, J. Konishi, and S. Sasayama Myocardial Lipid Metabolism in Compensated and Advanced Stages of Heart Failure: Evaluation by Canine Pacing Model with BMIPP J. Nucl. Med., January 1, 2001; 42(1): 124 - 129. [Abstract] [Full Text] [PDF]